What is he best known for?
The fields of study he is best known for:
- Inflammation
- Internal medicine
- Immune system
His primary scientific interests are in Inflammation, Immunology, Cyclooxygenase, Cell biology and Proinflammatory cytokine.
His Inflammation research is multidisciplinary, incorporating perspectives in Nitric oxide synthase and Signal transduction.
His multidisciplinary approach integrates Immunology and Extramural in his work.
His Cyclooxygenase research integrates issues from Phospholipase, Arachidonic acid, Prostaglandin D2, Leukotriene B4 and Pharmacology.
His biological study spans a wide range of topics, including Adipose tissue macrophages, T cell, CD11c and Macrophage-activating factor.
His work deals with themes such as Sodium salicylate, Phospholipase A2, Platelet-activating factor, Leukocyte migration and Eicosanoid, which intersect with Proinflammatory cytokine.
His most cited work include:
- Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines (2761 citations)
- Inducible cyclooxygenase may have anti-inflammatory properties. (1129 citations)
- Resolution of inflammation: state of the art, definitions and terms. (850 citations)
What are the main themes of his work throughout his whole career to date?
Derek W. Gilroy mainly investigates Inflammation, Immunology, Cyclooxygenase, Internal medicine and Pharmacology.
His work is dedicated to discovering how Inflammation, Prostaglandin are connected with Prostacyclin and other disciplines.
His is involved in several facets of Immunology study, as is seen by his studies on Immune system, Innate immune system, Cytokine, Proinflammatory cytokine and Monocyte.
His Cyclooxygenase research incorporates elements of Nimesulide, Prostaglandin D2 and Cyclopentenone prostaglandins.
His studies in Internal medicine integrate themes in fields like Gastroenterology and Endocrinology.
Derek W. Gilroy has included themes like Aspirin, Nitric oxide and Eicosanoid in his Pharmacology study.
He most often published in these fields:
- Inflammation (53.01%)
- Immunology (46.99%)
- Cyclooxygenase (16.27%)
What were the highlights of his more recent work (between 2015-2021)?
- Inflammation (53.01%)
- Immunology (46.99%)
- Immune system (15.66%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Inflammation, Immunology, Immune system, Internal medicine and Innate immune system.
He studies Lipid signaling, a branch of Inflammation.
His Immunology study incorporates themes from Disease and Pathology.
His Immune system research includes themes of Prostaglandin E2, Function and Antigen.
His research in the fields of Albumin, Serum albumin and Cirrhosis overlaps with other disciplines such as Human albumin solution.
His Innate immune system research includes elements of Decompensation, ARDS and Lymphocyte.
Between 2015 and 2021, his most popular works were:
- The fate and lifespan of human monocyte subsets in steady state and systemic inflammation. (331 citations)
- Resolution of inflammation: a new therapeutic frontier. (328 citations)
- Chronic inflammation in the etiology of disease across the life span (312 citations)
In his most recent research, the most cited papers focused on:
- Inflammation
- Internal medicine
- Immune system
Derek W. Gilroy mostly deals with Inflammation, Immunology, Immune system, Lipid signaling and Neuroscience.
His Inflammation research integrates issues from Disease and Homeostasis.
Immunology is closely attributed to Efferocytosis in his research.
His studies deal with areas such as Prostaglandin E, Functional recovery and Kinase, Cell biology as well as Immune system.
His research in Lipid signaling intersects with topics in Eicosapentaenoic acid, Docosahexaenoic acid, Cell signaling and Arachidonic acid.
Derek W. Gilroy interconnects Translational research, Function, Inflammatory mediator, Autoimmunity and Drug discovery in the investigation of issues within Neuroscience.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
